间接与直接靶向STN DBS治疗帕金森病的比较:手术方法与15年时间跨度的临床结局
本研究评估帕金森病患者从基于图谱的间接靶向方法(iTM)转为基于MRI的直接靶向(dTM)行丘脑底核脑深部电刺激(STN DBS)的结局,假设dTM更优。2014至2017年连续25例患者接受dTM STN DBS并随访1年,与早期iTM研究结果比较。dTM术后12个月,服药和刺激状态下UPDRS七项参数中六项显著改善(p<0.001),日常活动能力和运动评分分别改善41%和62%,异动症和波动均减少81%,左旋多巴等效剂量和每日总左旋多巴等效剂量分别显著降低62%和55%(p<0.001),5例(20%)术后12个月未用左旋多巴药物。
要点
- dTM STN DBS术后12个月,服药和刺激状态下UPDRS七项参数中六项显著改善(p<0.001)。
- 日常活动能力(UPDRSII)和运动评分(UPDRSIII)分别改善41%和62%。
- 异动症和波动均减少81%,左旋多巴等效剂量和每日总左旋多巴等效剂量分别降低62%和55%(p<0.001)。
核心结论
- 基于先进神经影像的手术技术发展改善了帕金森病STN DBS的结局。
研究设计与样本
- 2014至2017年连续25例帕金森病患者接受dTM STN DBS手术并随访1年,与早期iTM STN DBS研究结果进行比较。
主要发现
- dTM STN DBS术后12个月,服药和刺激状态下UPDRS七项参数中六项显著改善(p<0.001)。
- 日常活动能力(UPDRSII)和运动评分(UPDRSIII)分别改善41%和62%。
- 异动症和波动均减少81%。
- dTM组左旋多巴等效剂量和每日总左旋多巴等效剂量分别较基线显著降低62%和55%(p<0.001)。
- 5例(20%)患者术后12个月未用左旋多巴药物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep brain stimulation (DBS) in the subthalamic nucleus (STN) is used in advanced Parkinson's disease (PD) for reducing motor fluctuations and the side effects of antiparkinsonian medication (APM). The development of neuroimaging has enabled the direct targeting of the STN. The aim of this study is to evaluate the outcome in patients with PD using STN DBS when changing from atlas-based indirect targeting method (iTM) to direct MRI-based targeting (dTM) assuming dTM is superior. METHODS: Twenty-five consecutive PD patients underwent dTM STN DBS surgery from 2014 to 2017 with follow-up for 1 year. The neuroimaging, surgical method, outcome in Unified Parkinson's Disease Rating Scale (UPDRS) scores, and reduction of APM are described and compared with the results of an earlier iTM STN DBS study. RESULTS: Twelve months after a dTM STN DBS, significant improvement (p < 0.001) was seen in six out of seven parameters of UPDRS when patients had medication (medON) and stimulation (stimON). The activities of daily living (UPDRSII) and motor scores (UPDRSIII) improved by 41% and 62%, respectively. Dyskinesias and fluctuations were both reduced by 81%. In dTM STN DBS group, the levodopa equivalent dose (LED) and the total daily levodopa equivalent dose (LEDD) were significantly decreased by 62% and 55%, respectively, compared with the baseline (p < 0.001). Five patients (20%) were without levodopa medication 12 months after the operation. CONCLUSIONS: The development of surgical technique based on advanced neuroimaging has improved the outcome of PD STN DBS.
引用
- Lahtinen MJ, Haapaniemi TH, Kauppinen MT, et al. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan. Acta Neurochir (Wien). 2020. PMID: 32103343. doi:10.1007/s00701-020-04269-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。